Altos Labs

Reversing aging at the cellular level

San Francisco, CA, US

Biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience.

Shareable draft

Check out Altos Labs on @MedStartr Today Biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience. #Aging #CellularHealthDecline #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/g7lFG73pClY

Get Involved in Altos Labs

How We Help

Problem Statement

The decline of cell health and resilience, often associated with aging and disease.

Core Technology

Partial epigenetic cell reprogramming that does not destroy cell identity

Key Differentiators

Broadened senotherapeutics capabilities through acquisition of Dorian Therapeutics

Clinical Focus

Aging; Cellular Therapy; Regenerative Medicine

Company Info

Business Model: Service
Founded: 2022
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.altoslabs.com

Disease Areas

Aging Cellular Health Decline

Technologies

Cellular Rejuvenation ProgrammingEpigenetic Cell ReprogrammingSenotherapeuticsBiotechnology

Clinical & IP

🔬

Clinical Validation

Preclinical: Demonstrated lifespan and healthspan extension in mouse models. Clinical: Early human safety testing initiated August 2025. FDA status: No IND approval or clinical trials launched yet. Acquired Dorian programs showing promise in lung fibrosis and osteoarthritis models. CMO appointment (Dr. Joan Mannick) signals clinical advancement ahead.

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Altos Labs?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.